QURE
uniQure N.V. · Healthcare · Market cap $1.5B(Price slightly stale)
Insiders sold $17.9M net in the last 90 days ·11 sellers, 0 buyers· 14 of 23 sales under Rule 10b5-1 plans· latest Form 4 filed Jul 7, 2026
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$22.1M
reported sales (SEC code S)
Unique Insiders
12
in the rolling window
Latest filing
Jul 7, 2026
Kapusta Matthew C
uniQure N.V. (QURE) has 35 SEC Form 4 filings (90 transaction rows) in the rolling window, disclosed by 12 distinct insiders. Most recent filing: Jul 7, 2026.
Inside the rolling window, 12 insiders at uniQure N.V. reported no open-market purchases and 37 open-market sales totaling $22.1M. The most active filer is CEO, Managing Director Kapusta Matthew C with 8 filings. Insiders have net sold $20.0M over the trailing 6 months. The most recent open-market filing is a sale of 21,082 shares by CEO, Managing Director Kapusta Matthew C, dated Jul 2, 2026, worth $952K.
- Industry:Biotechnology
- CEO:Matthew C. Kapusta
- Employees:221
- HQ:Amsterdam, NH, NL
- IPO:2014-02-05
| Source | |||||||
|---|---|---|---|---|---|---|---|
| CEO, Managing Director | Sale | 21,082 | $952K | Jul 7 | -43.3% | SEC ↗ | |
| Chief Medical Officer | Sale | 30,000 | $1.4M | Jul 2 | -43.9% | SEC ↗ | |
| Director | Sale | 21,167 | $983K | Jul 2 | -43.9% | SEC ↗ | |
| Chief Medical Officer | Sale | 1,434 | $67K | Jun 30 | -49.1% | SEC ↗ | |
| CEO, Managing Director | Sale | 6,696 | $335K | Jun 26 | -50.6% | SEC ↗ | |
| CEO, Managing Director | Sale | 28,716 | $1.4M | Jun 26 | -50.6% | SEC ↗ | |
Kapusta Matthew CFirst in 4 months | CEO, Managing Director | Sale | 164,429 | $7.3M | Jun 22 | — | SEC ↗ |
Kapusta Matthew CFirst in 4 months | CEO, Managing Director | Sale | 41,671 | $2.1M | Jun 22 | — | SEC ↗ |
| Director | Sale | 11,685 | $526K | Jun 22 | — | SEC ↗ | |
| Director | Sale | 5,295 | $225K | Jun 22 | — | SEC ↗ | |
Potts JeannetteFirst in 3 months | Chief Legal Officer | Sale | 5,237 | $145K | Jun 17 | — | SEC ↗ |
| Director | Sale | 10,000 | $279K | Jun 17 | — | SEC ↗ | |
O'Keefe KylieFirst filing | Chief Customer & Strat Officer | Sale | 15,936 | $431K | Jun 12 | — | SEC ↗ |
Meek David D.First filing | Director | Sale | 1,993 | $54K | Jun 12 | — | SEC ↗ |
Balachandran MadhavanFirst filing | Director | Sale | 1,993 | $54K | Jun 12 | — | SEC ↗ |
| Director | Sale | 1,993 | $54K | Jun 12 | — | SEC ↗ | |
Gut RobertFirst in 5 months | Director | Sale | 7,552 | $197K | Jun 12 | — | SEC ↗ |
Gut RobertFirst in 5 months | Director | Sale | 2,726 | $74K | Jun 12 | — | SEC ↗ |
Springhorn Jeremy P.First filing | Director | Sale | 1,993 | $54K | Jun 12 | — | SEC ↗ |
| Director | Sale | 1,993 | $54K | Jun 12 | — | SEC ↗ | |
Jacques Rachelle SuzanneFirst filing | Director | Sale | 1,993 | $54K | Jun 12 | — | SEC ↗ |
Kaye JackFirst in 5 months | Director | Sale | 2,645 | $79K | Jun 5 | — | SEC ↗ |
| Chief Medical Officer | Sale | 45,000 | $1.1M | May 12 | — | SEC ↗ | |
| Chief Financial Officer | Sale | 12,000 | $109K | Mar 6 | — | SEC ↗ | |
| Chief Medical Officer | Sale | 808 | $7K | Mar 6 | — | SEC ↗ |
Earnings: last 7 quarters
Frequently asked questions
How many SEC Form 4 insider filings does QURE have?
uniQure N.V. (QURE) has 35 SEC Form 4 filings (90 transaction rows) in the rolling 365-day window, disclosed by 12 distinct insiders. Most recent filing: Jul 7, 2026.
When was the most recent SEC Form 4 filing for QURE?
The most recent Form 4 filing for QURE on Tracefour is dated Jul 7, 2026.
Who is the most active insider at QURE?
The most active SEC Form 4 filer at QURE in the rolling window is CEO, Managing Director Kapusta Matthew C, with 8 filings.
What is the net insider flow at QURE over the last 6 months?
Over the trailing 180 days, insiders at QURE have net sold $20.0M based on SEC Form 4 disclosures.
What is the total insider buy and sell value at QURE in the current window?
Inside the rolling window, insiders at QURE bought $0 and sold $22.1M based on SEC Form 4 filings.
Can I get alerts for QURE insider trading?
Yes. Tracefour sends a free email when a new SEC Form 4 purchase or sale is filed at uniQure N.V. (QURE). Alerts are set per company from the page itself, there is no paid tier, and each email links to the original filing on SEC EDGAR.
Related companies
uniQure N.V. is in the Healthcare sector.